Your browser doesn't support javascript.
A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice.
Marquez, Carina; Kerkhoff, Andrew D; Naso, Jamie; Contreras, Maria G; Castellanos Diaz, Edgar; Rojas, Susana; Peng, James; Rubio, Luis; Jones, Diane; Jacobo, Jon; Rojas, Susy; Gonzalez, Rafael; Fuchs, Jonathan D; Black, Douglas; Ribeiro, Salustiano; Nossokoff, Jen; Tulier-Laiwa, Valerie; Martinez, Jacqueline; Chamie, Gabriel; Pilarowski, Genay; DeRisi, Joseph; Petersen, Maya; Havlir, Diane V.
  • Marquez C; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America.
  • Kerkhoff AD; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America.
  • Naso J; Unidos en Salud, San Francisco, California, United States of America.
  • Contreras MG; Unidos en Salud, San Francisco, California, United States of America.
  • Castellanos Diaz E; Department of Medicine, University of California, San Francisco, California, United States of America.
  • Rojas S; Clínica Martín Baró, San Francisco, California, United States of America.
  • Peng J; The San Francisco Latino Task Force-Response to COVID-19, San Francisco, California, United States of America.
  • Rubio L; Unidos en Salud, San Francisco, California, United States of America.
  • Jones D; Clínica Martín Baró, San Francisco, California, United States of America.
  • Jacobo J; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, United States of America.
  • Rojas S; The San Francisco Latino Task Force-Response to COVID-19, San Francisco, California, United States of America.
  • Gonzalez R; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America.
  • Fuchs JD; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America.
  • Black D; Unidos en Salud, San Francisco, California, United States of America.
  • Ribeiro S; The San Francisco Latino Task Force-Response to COVID-19, San Francisco, California, United States of America.
  • Nossokoff J; The San Francisco Latino Task Force-Response to COVID-19, San Francisco, California, United States of America.
  • Tulier-Laiwa V; San Francisco Department of Public Health, San Francisco, California, United States of America.
  • Martinez J; San Francisco Department of Public Health, San Francisco, California, United States of America.
  • Chamie G; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, California, United States of America.
  • Pilarowski G; Bay Area Phlebotomy and Laboratory Services (BayPLS), San Francisco, California, United States of America.
  • DeRisi J; Bay Area Phlebotomy and Laboratory Services (BayPLS), San Francisco, California, United States of America.
  • Petersen M; The San Francisco Latino Task Force-Response to COVID-19, San Francisco, California, United States of America.
  • Havlir DV; Unidos en Salud, San Francisco, California, United States of America.
PLoS One ; 16(9): e0257111, 2021.
Article in English | MEDLINE | ID: covidwho-1430532
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

COVID-19 vaccine coverage in the Latinx community depends on delivery systems that overcome barriers such as institutional distrust, misinformation, and access to care. We hypothesized that a community-centered vaccination strategy that included mobilization, vaccination, and "activation" components could successfully reach an underserved Latinx population, utilizing its social networks to boost vaccination coverage.

METHODS:

Our community-academic-public health partnership, "Unidos en Salud," utilized a theory-informed approach to design our "Motivate, Vaccinate, and Activate" COVID-19 vaccination strategy. Our strategy's design was guided by the PRECEDE Model and sought to address and overcome predisposing, enabling, and reinforcing barriers to COVID-19 vaccination faced by Latinx individuals in San Francisco. We evaluated our prototype outdoor, "neighborhood" vaccination program located in a central commercial and transport hub in the Mission District in San Francisco, using the Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework during a 16-week period from February 1, 2021 to May 19, 2021. Programmatic data, city-wide COVID-19 surveillance data, and a survey conducted between May 2, 2021 and May 19, 2021 among 997 vaccinated clients ≥16 years old were used in the evaluation.

RESULTS:

There were 20,792 COVID-19 vaccinations administered at the neighborhood site during the 16-week evaluation period. Vaccine recipients had a median age of 43 (IQR 32-56) years, 53.9% were male and 70.5% were Latinx, 14.1% white, 7.7% Asian, 2.4% Black, and 5.3% other. Latinx vaccinated clients were substantially more likely than non-Latinx clients to have an annual household income of less than $50,000 a year (76.1% vs. 33.5%), be a first-generation immigrant (60.2% vs. 30.1%), not have health insurance (47.3% vs. 16.0%), and not have access to primary care provider (62.4% vs. 36.2%). The most frequently reported reasons for choosing vaccination at the site were its neighborhood location (28.6%), easy and convenient scheduling (26.9%) and recommendation by someone they trusted (18.1%); approximately 99% reported having an overall positive experience, regardless of ethnicity. Notably, 58.3% of clients reported that they were able to get vaccinated earlier because of the neighborhood vaccination site, 98.4% of clients completed both vaccine doses, and 90.7% said that they were more likely to recommend COVID-19 vaccination to family and friends after their experience; these findings did not substantially differ according to ethnicity. There were 40.3% of vaccinated clients who said they still knew at least one unvaccinated person (64.6% knew ≥3). Among clients who received both vaccine doses (n = 729), 91.0% said that after their vaccination experience, they had personally reached out to at least one unvaccinated person they knew (61.6% reached out to ≥3) to recommend getting vaccinated; 83.0% of clients reported that one or more friends, and/or family members got vaccinated as a result of their outreach, including 18.9% who reported 6 or more persons got vaccinated as a result of their influence.

CONCLUSIONS:

A multi-component, "Motivate, Vaccinate, and Activate" community-based strategy addressing barriers to COVID-19 vaccination for the Latinx population reached the intended population, and vaccinated individuals served as ambassadors to recruit other friends and family members to get vaccinated.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hispanic or Latino / Residence Characteristics / COVID-19 Vaccines Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0257111

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Hispanic or Latino / Residence Characteristics / COVID-19 Vaccines Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0257111